Factor VIII (human coagulation factor VIII) / Hemobras - LARVOL DELTA

Sobi showcases commitment to haemophilia community at EAHAD 2021 (PRNewswire.co.uk) - "Sobi will present data at the 14th European Association of Haemophilia and Allied Disorders (EAHAD) virtual conference from 3-5 February 2021, showing evidence further supporting the safety, efficacy and long-term benefits of its Fc-fusion extended half-life (EHL) products for the treatment of haemophilia. The data to be presented also supports Sobi's ongoing commitment to liberating life for people with haemophilia, with a new product candidate in development."

Clinical data • Observational data • Retrospective data • Hemophilia

Multidisciplinary Team Management of Severe Hemophilia A with Non-ST Elevation Myocardial Infarction (Dovepress) - "Elderly patients with hemophilia A have an increased risk of age-related thrombotic diseases, such as myocardial infarction. The relevant risk factors are comparable to those in the normal elderly population. However, their diagnosis and treatment are difficult."

Clinical • Hemophilia